BRCA1 and cancer: The downregulation of the gene BRCA1 (breast cancer 1, early onset – exon 4, transcriptional variants 1b, delta 11b, delta 14–17) has been shown to correlate with an insensitivity to the chemotherapeutic agent doxorubicin37.